Terms ending in 2037
Janssen Research & Development, LLC
Every in-force patent on Janssen Research & Development, LLC's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,219,936 | Therapeutic Agent Delivery Device with Advanceable Cannula and Needle In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US D946,141 | Autoinjector In force · High confidence | Janssen Pharmaceuticals, Inc. | In force | High confidence | |
| US D946,750 | Grip Accessory for an Injection Device In force · High confidence | Janssen Pharmaceuticals, Inc. | In force | High confidence | |
| US 10,273,268 | HIV Vaccine Formulation In force · High confidence | Janssen Vaccines & Prevention B.V. | In force | High confidence | |
| US 10,934,328 | HIV Vaccine Formulation In force · High confidence | Janssen Vaccines & Prevention B.V. | In force | High confidence | |
| US 11,168,068 | Tau Pet Imaging Ligands In force · High confidence | Janssen Pharmaceutica N.V. | In force | High confidence | |
| US D958,330 | Injection Device Accessory In force · High confidence | Janssen Pharmaceuticals, Inc. | In force | High confidence | |
| US 10,322,028 | Method and Apparatus for Sensing Position Between Layers of an Eye In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 10,428,134 | Immunoglobulins and Uses Thereof In force · Medium confidence | Janssen Pharmaceutica N.V. | In force | Medium confidence | |
| US 10,787,495 | Immunoglobulins and Uses Thereof In force · Medium confidence | Janssen Research & Development, LLC | In force | Medium confidence | |
| 1 more term end in 2037 · Pro | |||||
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11.
1 of these is in force and held by Janssen Research & Development, LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.